Cases & Deals

Celldex Therapeutics develops worldwide patent portfolios for receptor tyrosine kinase antibody therapeutics

Clients Celldex Therapeutics, Inc.

Jones Day is developing worldwide patent portfolios for Celldex Therapeutics, Inc.'s receptor tyrosine kinase antibody therapeutics, including anti-ErbB3 and anti-KIT antibody clinical candidates.